Table 1.
Comparison of current clinical practice guidelines for chronic hepatitis B management
| KASL | AASLD | EASL | APASL | |
|---|---|---|---|---|
| Published year | Jun-19 | Apr-18 | Aug-17 | Jan-16 |
| Journal | Clinical Molecular Hepatology | Hepatology | Journal of Hepatology | Hepatology International |
| Type | Clinical practice guidelines | Guidance incorporated with guidelines | Clinical practice guidelines | Clinical practice guidelines |
| Listed author(s) | KASL | An expert panel of the AASLD | EASL | A panel of Asian experts chosen by the APASL |
| Recommendation | GRADE | Guidance developed by the consensus of an expert panel, GRADE (2016) | GRADE | GRADE |
| Interval since the previous update | 3 years | 2 years | 5 years | 4 years |
| Target population | Korean | American | European | Asian |
| Suggested normal ALT (IU/L) | ||||
| Male | <34 | <35 | <40 | <40 |
| Female | <30 | <25 | <40 | <40 |
KASL, Korean Association for the Study of the Liver; AASLD, American Association for the Study of Liver Diseases; EASL, European Association for the Study of the Liver; APASL, Asian-Pacific Association for the Study of the Liver; GRADE, Grading of Recommendations Assessment, Development and Evaluation system; ALT, alanine aminotransferase.